These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25916525)

  • 1. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
    Lin E; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics with antidepressants in the STAR*D study.
    Lin E; Chen PS
    Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and prospects in pharmacogenetics of antidepressant drugs.
    Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 6. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant pharmacogenetics.
    Singh AB; Bousman CA; Ng C; Berk M
    Curr Opin Psychiatry; 2014 Jan; 27(1):43-51. PubMed ID: 24270480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
    Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
    Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
    Fabbri C; Serretti A
    Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.
    Frieling H; Tadić A
    Int Rev Psychiatry; 2013 Oct; 25(5):572-8. PubMed ID: 24151802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase (COMT) pharmacogenetics in the treatment response phenotypes of major depressive disorder (MDD).
    Kocabas NA
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):264-72. PubMed ID: 22483292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder.
    Ahmed AT; Weinshilboum R; Frye MA
    Clin Pharmacol Ther; 2018 May; 103(5):767-769. PubMed ID: 29388201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
    Sasayama D; Hiraishi A; Tatsumi M; Kamijima K; Ikeda M; Umene-Nakano W; Yoshimura R; Nakamura J; Iwata N; Kunugi H
    Pharmacogenomics J; 2013 Aug; 13(4):354-8. PubMed ID: 22584459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.